@Biostock Dr Chris Behrenbruch was instrumental in the IPO of TLX and is the founding CEO to the best of my knowledge. He as an extensive pedigree in the healthcare space and years ago had a blog called ASX Longtail where he was quite scathing of some ASX listed healthcare and biotech stocks, their science, trial practices and reporting. Of note Starpharma was prominent. I will bring up the thread history on a separate thread in a moment.
GLTAH
Starpharma's Radiotherapeutics and Telix's Molecularly Targeted Radiation platform, page-8
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.8¢ |
Change
0.001(1.03%) |
Mkt cap ! $40.97M | |||
| Open | High | Low | Value | Volume |
| 9.7¢ | 9.9¢ | 9.7¢ | $44.76K | 455.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 824859 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 121525 | 5 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |